Sleep
Axsome Presents Q1 Results, Advances in Sleep Medicine Pipeline
Summary: Axsome Therapeutics’ Q1 2024 report highlights advancements in its sleep medicine pipeline, with positive phase 3 results for AXS-12 in narcolepsy treatment and revenue growth for Sunosi, reflecting strong financial performance and progress in addressing sleep disorders. Additionally, the company showcases promising developments in its neuroscience portfolio, including ongoing clinical trials for solriamfetol in […]
RKI – Behavior – Topic sheet: Sleep
central message Loud KiGGS In Wave 2 (2014–2017), 81% of children and adolescents achieved the age-specific recommended sleep duration. In adolescence, the proportion of those who achieve age-specific sleep recommendations decreases Boys and girls achieve the age-specific sleep recommendations at approximately equal rates. background Sufficient sleep is important for the healthy development of children and […]